Intracoronary ultrasound in acute coronary syndromes: from characterization of vulnerable plaques to guidance of percutaneous treatment of complex stenoses.

Our current knowledge on the substrate and genesis of acute coronary syndromes (ACS) results from the integration of pathological, angiographic, and intracoronary imaging techniques. To summarize briefly the current paradigm, eight differentiated stages of development of atherosclerotic lesions are currently accepted, defined not only by the cellular elements involved, but also by the appearance of sudden alterations of plaque structure and coronary thrombosis. The latter constitutes not only the dominant substrate for the most devastating manifestations of coronary artery disease, but also accelerates plaque size at a faster pace than in earlier stages. The composition of atherosclerotic plaque varies significantly along the different evolutive stages, and thus includes cellular (macrophage, smooth muscle cells) and noncellular elements (glicosaminglycan or collagen-rich cellular matrix, extracellular lipid deposits, calcification, fresh, or organized thrombus) in a varying proportion. Furthermore, a dynamic process of vessel remodeling occurs along the atherosclerotic process, resulting, in most cases, in a protective mechanism against myocardial ischemia by preserving luminal dimensions during plaque enlargement. Intravascular ultrasound (IVUS) is one of the intracoronary imaging techniques that has contributed to the understanding of these changes in man. In addition, IVUS has the potential of being a useful clinical tool for predicting the chances of future acute coronary events by identifying vulnerable plaques, of characterizing which is the culprit lesion in ACS, and in guiding revascularization procedures in the treacherous field of thrombotic coronary syndromes. In this article, we review the current evidence on the potential of IVUS imaging for fulfilling these purposes.